(NaturalNews) Researchers at ChristianaCare’s Gene Editing Institute successfully used CRISPR-Cas9 to disable the NRF2 gene, reversing chemotherapy resistance i…
Scientists use CRISPR gene editing to reverse chemo resistance in lung cancer
Estimated read time
1 min read
You May Also Like
More From Author
How Bob Woodward betrayed the source who made him famous
November 16, 2026
Magnesium Linked to Lower Atrial Fibrillation Risk, Study Finds
November 16, 2026
